… Of the 35,961 patients with follicular lymphoma included in the current study, 63% had
stage I disease, 79% were without extranodal disease, and 61% were aged >60 years. RT use …

… The appropriate management of this disease ranges from … focus on the optimal management
of follicular lymphoma, including … with promising activity in follicular lymphoma that have the …

… ) comparing obinutuzumab-chemotherapy versus obinutuzumab-lenalidomide or
obinutuzumabumbralisib will be helpful to further elucidate the optimal management of these …

… patients, the optimal timing of rituximab, the … the management of relapsed disease. We
provide an evidence-based discussion on these and other issues regarding the management of FL…

… Follicular Lymphoma (FL) is an indolent lymphoma and may … lymphoma (NHL) type after
diffuse large B‐cell lymphoma. In … study results on the management of patients with newly …

Follicular lymphoma (FL) is a heterogeneous disease. For many it is experienced as a chronic,
relapsing, indolent condition with long overall survival (OS). Most people affected have …

Background Follicular lymphomas (FLs) are a heterogeneous group of lymphomas. No
standard of care exists, and the management of these patients is highly individualized. Methods …

… B cell lymphomas are named according to the location of the related cell type within the
lymphoid follicle 3 and include follicular lymphoma (FL) and diffuse large B cell lymphoma (…

… patients with grade 1 and 2 disease, the optimal treatment for patients with grade 3a
disease remains unclear: these patients were not included in either study. The FOLLO5 trial …

… The initial approach to the management of follicular lymphoma (FL) is challenging for …
Unfortunately, prognostic and other clinical factors are of limited value in guiding optimal selection …